Treatment with bioartificial liver improves lung injury in a swine model of partial hepatectomy and ischemia/reperfusion

International Journal of Artificial Organs

Volumn 33, Issue 2, 2010, Pages 105-113

  Arkadopoulos, Nikolaos ^a   Kalimeris, Konstantinos ^b   Papalois, Apostolos ^a   Nastos, Constantinos ^a   Papoutsidakis, Nikolaos ^a   Defterevos, George ^a   Zarkadis, Ioannis K ^c   Mikrou, Aggeliki ^c   Pafiti, Agatha ^a   Andreadou, Ioanna ^b   Kostopanagiotou, Georgia ^b   Smyrniotis, Vassilios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Bioartificial liver; Liver failure; Liver resection surgery; Liver lung interactions; Lung injury

Indexed keywords

ARTIFICIAL ORGANS;

BIOARTIFICIAL LIVER; HEPATIC ISCHEMIA; ISCHAEMIA-REPERFUSION; LIVER FAILURE; LIVER RESECTION SURGERY; LIVER RESECTIONS; LIVER-LUNG INTERACTION; LUNG INJURY; NITROTYROSINE; REPERFUSION;

BIOLOGICAL ORGANS;

3 NITROTYROSINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; MESSENGER RNA; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOARTIFICIAL LIVER; CONTROLLED STUDY; EXPERIMENTAL PIG; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; LUNG ALVEOLUS CELL; LUNG INJURY; LYMPHOCYTIC INFILTRATION; NONHUMAN; OXYGENATION; PARTIAL HEPATECTOMY; PROTEIN EXPRESSION; REPERFUSION INJURY;

EID: 77950199895     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300206     Document Type: Article

References (32)

1. Peralta C, Perales JC, Bartrons R, et al. The combination of ischemic preconditioning and liver bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am J Pathol 2002; 160: 2111-2122
2. Takamatsu Y, Shimada K, Yamaguchi K, Kuroki S, Chijiiwa K, Tanaka M. Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver. Dig Dis Sci 2006; 51: 571-579
3. Weinbroum AA, Kluger Y, Ben Abraham R, Shapira I, Karchevski E, Rudick V. Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion injury after liver no flow-reflow: A dose-response study. Transplantation 2001; 71: 300-306
4. Fernandez L, Heredia N, Peralta C, et al. Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation. Transplantation 2003; 76: 282-289
5. Kostopanagiotou G, Kalimeris K, Arkadopoulos N, Pafiti A, Panagopoulos D, Smyrniotis V, Vlahakos D, Routsi C, Lekka ME, Nakos G. Desferrioxamine attenuates minor lung injury following surgical acute liver failure. Eur Respir J 2009; 33: 1429-1436
6. Khalili TM, Navarro A, Ting P, et al. Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure. Artif Organs 2001; 25: 566-570
7. Germann PG, Häfner D. A rat model of acute respiratory distress syndrome (ARDS). Part 1. Time dependency of histological and pathological changes. J Pharmacol Toxicol Methods 1998; 40: 101-107
8. Samuel D, Ichai P, Feray C, et al. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation 2002; 73: 257-264
9. Demetriou AA, Brown RS, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-670
10. Singhal A, Neuberger J. Acute liver failure: Bridging to transplant or recovery - are we there yet? J Hepatol 2007; 46: 557-564
11. Jalan R, Sen S, Williams R. Prospects for extracorporeal liver support. Gut 2004; 53: 890-898
12. van de Kerkhove MP, Hoekstra R, van Gulik TM, Chamuleau RA. Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials 2004; 25: 1613-1625
13. Suh KS, Lilja H, Kamohara Y, et al. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver enriched and growth-associated transcription factors. J Surg Res 1999; 85: 243-250
14. Galhardo MA, Júnior CQ, Riboli Navarro PG, et al. Liver and lung late alterations following hepatic reperfusion associated to ischemic preconditioning or N-acetylcysteine. Microsurgery 2007; 27: 295-299
15. Hirsch J, Niemann CU, Hansen KC, et al. Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion. Crit Care Med 2008; 36: 1846-1854
16. Vanherweghem JL, Drukker W, Schwarz A. Clinical significance of blood-device interaction in hemodialysis. A review. Int J Artif Organs 1987; 10: 219-232
17. Tsai BM, Wang M, Pitcher JM, Meldrum KK, Meldrum DR. Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C. Am J Physiol Lung Cell Mol Physiol 2004; 287: L1215-9.
18. Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 inhibits pulmonary NF-kB activation and lung injury induced by hepatic ischemia-reperfusion. Am J Physiol Lung Cell Mol Physiol 1999; 277: 919-923
19. Simon A, Rai V, Fanburg B, Cochran B. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 1998; 275: C1640-52.
20. Hierholzer C, Kalff J, Omert L, et al. Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. Am J Physiol Lung Cell Mol Physiol 1998; 275: 611-621
21. Müller AM, Cronen C, Müller KM, Kirkpatrick CJ. Heterogeneous expression of cell adhesion molecules by endothelial cells in ARDS. J Pathol 2002; 198: 270-275
22. Mulligan MS, Miyasaka M, Ward PA. Protective effects of combined adhesion molecule blockade in models of acute lung injury. Proc Assoc Am Physicians 1996; 108: 198-208.
23. Scotté M, Masson S, Lyoumi S, et al. Cytokine gene expression in liver following minor or major hepatectomy in rat. Cytokine 1997; 9: 859-867
24. Hayashi Y, Sawa Y, Nishimura M, Fukuyama N, Ohtake S, Nakazawa H, Matsuda H. Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response. Eur J Cardiothorac Surg 2004; 26: 276-280
25. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994; 94: 2407-2413
26. Lin HI, Chou SJ, Wang D, Feng NH, Feng E, Chen CF. Reperfusion liver injury induces down-regulation of eNOS and up-regulation of iNOS in lung tissues. Transplant Proc 2006; 38: 2203-2206
27. Hallbeck AL, Walz TM, Wasteson A. Interleukin-6 enhances transforming growth factor-alpha mRNA expression in macrophage-like human monocytoid (U-937-1) cells. Biosci Rep 2001; 21: 325-339
28. Tomiya T, Ogata I, Fujiwara K. Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am J Pathol 1998; 153: 955-961
29. Chesnutt A, Kheradmand F, Folkesson HG, Alberts MB, Matthay MA. Soluble transforming growth factor-a is present in the pulmonary edema fluid of patients with acute lung injury. Chest 1997; 111: 652-656
30. Folkesson HG, Pittet JF, Nitenberg G, Matthay MA. TGF-a increases alveolar liquid clearance in anesthetized ventilated rats. Am J Physiol Lung Cell Mol Physiol 1996; 271: L236-44.
31. Kheradmand F, Folkesson HG, Shum L, Derynk R, Pytela R, Matthay MA. Transforming growth factor-a enhances alveolar epithelial cell repair in a new in vitro model. Am J Physiol 1994; 267: L728-38.
32. Doria C, MandalA L, Scott VL, et al. Noncardiogenic pulmonary edema induced by a molecular adsorbent recirculating system: case report. Int J Artif Organs 2003; 6: 282-285